Dabigatran ethyl ester
≥99%
- Product Code: 61739
CAS:
429658-95-7
| Molecular Weight: | 499.56 g./mol | Molecular Formula: | C₂₇H₂₉N₇O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Dabigatran ethyl ester is primarily used as an intermediate in the synthesis of dabigatran, an oral anticoagulant. Dabigatran itself is widely applied in medical settings to prevent and treat thromboembolic disorders. It is particularly effective in reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is used for the prevention of venous thromboembolism in patients undergoing hip or knee replacement surgery. The drug works by directly inhibiting thrombin, a key enzyme in the blood coagulation cascade, thereby preventing the formation of blood clots. Its advantages include a fixed dosing regimen, no need for routine blood monitoring, and fewer dietary restrictions compared to traditional anticoagulants like warfarin.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $371.67 |
+
-
|
| 0.010 | 10-20 days | $602.71 |
+
-
|
Dabigatran ethyl ester
Dabigatran ethyl ester is primarily used as an intermediate in the synthesis of dabigatran, an oral anticoagulant. Dabigatran itself is widely applied in medical settings to prevent and treat thromboembolic disorders. It is particularly effective in reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is used for the prevention of venous thromboembolism in patients undergoing hip or knee replacement surgery. The drug works by directly inhibiting thrombin, a key enzyme in the blood coagulation cascade, thereby preventing the formation of blood clots. Its advantages include a fixed dosing regimen, no need for routine blood monitoring, and fewer dietary restrictions compared to traditional anticoagulants like warfarin.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :